Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BI 764198 Efficacy and Safety in Prevention/Progression of ARDS and ARDS-related Complications Secondary to COVID-19 (ACTION ON COVID-19)

NCT04604184 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT04604184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04604184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BI 764198 Efficacy and Safety in Prevention/Progression of ARDS and ARDS-related Complications Secondary to COVID-19 (ACTION ON COVID-19)
Lead sponsor
Boehringer Ingelheim
Phase
Phase 2
Overall status
Terminated
Start date
November 3, 2020
Completion date
May 31, 2021
Enrollment
133 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19